Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$816,977
+$572,747 QoQ
Shares Held
56,972
+117.4% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ZVRA ranks #149 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ZVRA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $816,977 56,972
2026-03-31 $244,230 26,205
2025-12-31 $599,870 66,950
2025-09-30 $350,499 36,856
2025-06-30 $263,003 29,853
2025-03-31 $230,197 30,734
2024-12-31 $247,705 29,701
2024-09-30 $124,620 17,957
2024-06-30 $134,166 27,381
2024-03-31 $138,665 23,908
2023-12-31 $155,619 23,759
2023-09-30 $101,079 20,971
2023-06-30 $92,054 18,050
2023-03-31 $27,923 5,077
2022-12-31 $23,289 5,074
2022-09-30 $32,135 5,150
2022-06-30 $27,593 6,187
2022-03-31 $45,903 9,126
2021-12-31 $170,123 19,532
2021-09-30 $366,397 39,271
2021-06-30 $73,317 5,719
2021-03-31 $30,589 3,325